n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid has been researched along with ST Elevation Myocardial Infarction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| El-Saadi, W; Engvall, J; Karlsson, JE; Maret, E | 1 |
| Ali, M; Andersson, RG; El-Saadi, W; Engvall, JE; Jynge, P; Karlsson, JE; Maret, E; Puskar, W; Skogvard, P | 1 |
1 trial(s) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and ST Elevation Myocardial Infarction
| Article | Year |
|---|---|
Mangafodipir as a cardioprotective adjunct to reperfusion therapy: a feasibility study in patients with ST-segment elevation myocardial infarction.
Topics: Dose-Response Relationship, Drug; Edetic Acid; Feasibility Studies; Female; Follow-Up Studies; Heart Ventricles; Humans; Infusions, Intravenous; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Percutaneous Coronary Intervention; Pyridoxal Phosphate; Retrospective Studies; ST Elevation Myocardial Infarction; Treatment Outcome; Ventricular Function, Left | 2015 |
1 other study(ies) available for n,n'-bis(pyridoxal-5-phosphate)ethylenediamine-n,n'-diacetic acid and ST Elevation Myocardial Infarction
| Article | Year |
|---|---|
Four- to seven-year follow-up of pharmacological postconditioning with mangafodipir as an adjunct to primary PCI in ST-segment elevation myocardial infarction.
Topics: Follow-Up Studies; Humans; Percutaneous Coronary Intervention; ST Elevation Myocardial Infarction; Stroke Volume; Treatment Outcome; Ventricular Function, Left | 2023 |